Rs10 Lakh Penalty: CCPA Slams Meesho for Selling Walkie-Talkies Without Mandatory Legal Disclosures

The CCPA has fined Meesho Rs 10 lakh for allowing the sale of walkie-talkies without essential legal and compliance disclosures. The watchdog said the platform misled consumers and failed to prevent the listing of restricted radio devices.

Air India AI-171 Crash: Centre Forms High-Level Multi-Disciplinary Committee to Probe Ahmedabad-London Tragedy

The central government has formed a high-level multi-disciplinary committee to investigate the tragic crash of Air India Flight AI-171, which occurred shortly after takeoff from Ahmedabad en route to London.

“Gautam Adani Charged for Securities Fraud Conspiracy”: Adani Green

Today, On 27th November, Gautam Adani and several executives from Adani Green faced allegations of securities law violations related to a bribery scheme in India. The U.S. SEC’s complaints and criminal indictments indicate serious legal challenges for the Adani Group, leading to significant financial losses and declines in stock prices for Adani Green.

CJI Chandrachud Advises SEBI, SAT Caution During Market Surge, Calls for More Tribunal Benches

Today(on 4th July), Chief Justice of India D Y Chandrachud urged SEBI and SAT to exercise caution in the face of surging equity markets, highlighting the need for additional tribunal benches to stabilize operations. He emphasized the pivotal role of regulatory bodies in maintaining market stability and stressed the urgency of addressing the increased workload and pending appeals at SAT.

“Mercy for One, But What About the Rest”: SC Plight of Faceless Individuals Relying on Misleading Medication

On Wednesday (10th April): The Supreme Court of India expressed concern for public well-being, particularly regarding misleading advertisements and unregulated products. Justices emphasized that violations of the law, such as exploiting people’s trust with misleading claims, will not be tolerated. This relates to a recent contempt plea against Patanjali for marketing its product, Coronil, as a COVID-19 cure, violating drug advertising regulations.